Search

The fabrication of new membrane that is able to produce stable high power density is essential for the development of pressure retarded osmosis (PRO) technology. In this work, thin film composite (TFC) polyetherimide membranes with three different substrate structures were fabricated and characterized. The PRO performance of the resultant membrane was evaluated through two pressure cycle experiments and stability tests. The primary objective of this work is to systematically study PRO membrane’s mechanical stability and mass transfer properties under high operating pressures, which determine the power density of the membrane in the PRO process. Experiments revealed that water permeability ( A p ) and salt permeability ( B p ) under different pressures varied. The A p and B p are better indicators for examining the variation of PRO membrane structure under pressure. Within the operating pressure range of 17.2 bar, the top polyamide layer of TFC PEI-2# membrane mainly experienced a reversible deformation. In the two pressure cycle tests, the water flux, specific salt flux and power density obtained in the upward and downward measurements in each cycle are close to each other. The first cycle and the second cycle also show excellent reproducibility. The membrane was able to maintain almost unchanged water flux and power density of 12.8 W/m 2 at 17.2 bar over the 10 h testing time, suggesting the membrane’s great potential to be used in practical application in the future. [ABSTRACT FROM AUTHOR]

A scaled-up hollow fibre thin-film composite (TFC) module was successfully developed for organic solvent forward osmosis (OSFO) application in the pharmaceutical industry. The membrane consists of cross-linked P84 polyimide substrate with a polyamide selective layer, formed via interfacial polymerisation. The performance of the lab-scale module was compared to the scaled-up module in reverse osmosis and forward osmosis modes. The results from both tests revealed that the solvent permeability of the scaled-up module decreased while its selectivity increased slightly. This might be caused by the uneven distribution of liquids during interfacial polymerisation, leading to varied membrane performance. The scaled-up module was further tested for OSFO performance using a range of PEG-400 concentrations (0.5–2 M) in acetone and isopropanol as draw solutions. At 2 M PEG-400 concentration, the module demonstrated high isopropanol and acetone permeability of 0.63 LMH and 13.9 LMH, respectively. Moreover, the reverse solute flux of PEG-400 in acetone and isopropanol were relatively low at 0.188 g/l and 0.153 g/l, respectively. The module was further tested for OSFO application in the pharmaceutical industry by concentrating levofloxacin in acetone, using 2 M PEG-400 as draw solution. The process was able to concentrate levofloxacin from 1000 ppm to 16,000 ppm with very low reverse solute flux of 0.178 g/l. Therefore, this work presents a scalable TFC membrane for OSFO application in the pharmaceutical industry. [Display omitted] • Scaled-up module (0.4 m2) of TFC hollow fibre membrane for organic solvent forward osmosis process was successfully fabricated. • High porosity (79%) and low structural parameter (217 μm) for membrane substrate was achieved. • Membrane exhibited excellent acetone and IPA solvent flux of 13.9 LMH and 0.63 LMH, respectively, using a 2 M PEG-400 draw solution. • A pharmaceutical stream was concentrated to a factor of 16 with low specific reverse solute flux [ABSTRACT FROM AUTHOR]

A scaled-up hollow fibre thin-film composite (TFC) module was successfully developed for organic solvent forward osmosis (OSFO) application in the pharmaceutical industry. The membrane consists of cross-linked P84 polyimide substrate with a polyamide selective layer, formed via interfacial polymerisation. The performance of the lab-scale module was compared to the scaled-up module in reverse osmosis and forward osmosis modes. The results from both tests revealed that the solvent permeability of the scaled-up module decreased while its selectivity increased slightly. This might be caused by the uneven distribution of liquids during interfacial polymerisation, leading to varied membrane performance. The scaled-up module was further tested for OSFO performance using a range of PEG-400 concentrations (0.5–2 M) in acetone and isopropanol as draw solutions. At 2 M PEG-400 concentration, the module demonstrated high isopropanol and acetone permeability of 0.63 LMH and 13.9 LMH, respectively. Moreover, the reverse solute flux of PEG-400 in acetone and isopropanol were relatively low at 0.188 g/l and 0.153 g/l, respectively. The module was further tested for OSFO application in the pharmaceutical industry by concentrating levofloxacin in acetone, using 2 M PEG-400 as draw solution. The process was able to concentrate levofloxacin from 1000 ppm to 16,000 ppm with very low reverse solute flux of 0.178 g/l. Therefore, this work presents a scalable TFC membrane for OSFO application in the pharmaceutical industry. [Display omitted] • Scaled-up module (0.4 m2) of TFC hollow fibre membrane for organic solvent forward osmosis process was successfully fabricated. • High porosity (79%) and low structural parameter (217 μm) for membrane substrate was achieved. • Membrane exhibited excellent acetone and IPA solvent flux of 13.9 LMH and 0.63 LMH, respectively, using a 2 M PEG-400 draw solution. • A pharmaceutical stream was concentrated to a factor of 16 with low specific reverse solute flux [ABSTRACT FROM AUTHOR]